J Int Assoc Physicians AIDS Care. 1998 Nov;4(11):22-3.

Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.

Abstract

AIDS:

Ronald C. Desrosiers is interviewed about the possibility of using a live-attenuated HIV vaccine in human trials. Desrosiers describes the processes that were used to develop a vaccine for SIV and talks about moving the trials from monkeys to humans. He proposes that terminally ill patients be allowed to receive the vaccine, since data from these patients could speed up the possibility of trials with healthy humans.

PMID:: 11366120; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

HighWire - PDF

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Save items

Related citations in PubMed

Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD. [J Int Assoc Physicians AIDS Ca...]
Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.
Desrosiers R. J Int Assoc Physicians AIDS Care. 1998 Mar; 4(3):45-6.
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease. [J Virol. 2005]
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.
Amara RR, Patel K, Niedziela G, Nigam P, Sharma S, Staprans SI, Montefiori DC, Chenareddi L, Herndon JG, Robinson HL, et al. J Virol. 2005 Dec; 79(24):15356-67.
Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine. [Trends Microbiol. 2001]
Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine.
Kuwata T, Miura T, Hayami M. Trends Microbiol. 2001 Oct; 9(10):475-80.
Review Live attenuated HIV vaccines: pitfalls and prospects. [Curr Opin Infect Dis. 2004]
Review Live attenuated HIV vaccines: pitfalls and prospects.
Whitney JB, Ruprecht RM. Curr Opin Infect Dis. 2004 Feb; 17(1):17-26.
Review Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine. [Expert Rev Vaccines. 2002]
Review Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
Das AT, Zhou X, Vink M, Klaver B, Berkhout B. Expert Rev Vaccines. 2002 Oct; 1(3):293-301.

See reviews... See all...

Cited by 1 PubMed Central article

Protection of macaques against AIDS with a live attenuated SHIV vaccine is of finite duration. [Virology. 2008]
Protection of macaques against AIDS with a live attenuated SHIV vaccine is of finite duration.
Kumar A, Liu Z, Sheffer D, Smith M, Singh DK, Buch S, Narayan O. Virology. 2008 Feb 20; 371(2):238-45. Epub 2007 Nov 7.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Will there be a live-attenuated HIV vaccine available for human safety trials by...
Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.
J Int Assoc Physicians AIDS Care. 1998 Nov ;4(11):22-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: